Biotransformation and clearance of 3-(phenylamino)propane-1,2-diol, a compound present in samples related to toxic oil syndrome, in C57BL/6 and A/J mice

Chemical Research in Toxicology

Volumn 12, Issue 12, 1999, Pages 1127-1137

  Ladona, Margarita G ^a,b   Bujons, Jordi ^b   Messeguer, Angel ^b   Ampurdanés, Coral ^a,b   Morató, Anna ^b   Corbella, Jacint ^c  

^a INST D INVESTIGACIONS B   (Spain)

^b DEPARTMENT OF ENVIRONMENTAL CHEMISTRY   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

3 (PHENYLAMINO)PROPANE 1,2 DIOL; ANILINE; BETA NAPHTHOFLAVONE; FATTY ACID DERIVATIVE; OLIVE OIL; PROPIONIC ACID DERIVATIVE; RAPESEED OIL; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BIOTRANSFORMATION; BODY FLUID; CONTROLLED STUDY; FOOD POISONING; MOUSE; NONHUMAN; SYNTHESIS; TOXIC OIL SYNDROME; URINALYSIS; WASTING SYNDROME;

ANIMALS; BETA-NAPHTHOFLAVONE; BIOTRANSFORMATION; ENZYME INDUCTION; INJECTIONS, INTRAPERITONEAL; MICE; MICE, INBRED C57BL; MICROSOMES, LIVER; PLANT OILS; POISONING; PROPYLENE GLYCOLS; SPECIES SPECIFICITY; SYNDROME;

ANIMALIA; MURINAE; SINAPIS ARVENSIS; TOSCANA VIRUS;

EID: 0033396646     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx990105j     Document Type: Article

References (46)

1. Gradjean, P., and Tarkowski, S., Eds. (1984) Toxic Oil Syndrome: mass food poisoning in Spain. Report of a WHO Meeting: Madrid, 21-25 March, 1983, World Health Organization Regional Office for Europe, Copenhagen, Denmark.
2. Tabuenca, J. M. (1981) Toxic allergic syndrome caused by ingestion of rapeseed oil denatured with aniline. Lancet 2, 567-568.
3. Diaz de Rojas, F., Castro-García, M., Abaitua-Borda, I., Alonso-Gordo, J. M., Posada de la Paz, M., Kilbourne, E. M., and Tabuenca-Oliver, J. M. (1987) The association of oil ingestion with Toxic Oil Syndrome in two convents. Am. J. Epidemiol. 125, 907-911.
4. Cañas, R., and Kilbourne, E. M. (1987) Oil ingestion and the Toxic Oil Syndrome. Results of a survey of residents of the Orcasur neighbourhood in Madrid Spain. Int. J. Epidemiol. 16, 3-6.
5. Rigau-Perez, J. G. (1984) Summary of case-control studies and case or cluster investigations. In Toxic Oil Syndrome: mass food poisoning in Spain. Report of a WHO Meeting: Madrid 21-25 March, 1983 (Gradjean, P., and Tarkowski, S., Eds.) pp 47-51, World Health Organization Regional Office for Europe, Copenhagen, Denmark.
6. Rigau-Perez, J. G., Pérez-Alvarez, L., Dueñas-Castro, S., Choi, K., Thacker, S. B., Germain, J. L., González-de-Andrés, G., Canada-Royo, L., and Pérez-Gallardo, F. (1984) Epidemiologic investigation of an oil-associated pneumonic paralytic eosinophilic syndrome in Spain. Am. J. Epidemiol. 119, 250-260.
7. Abaitua-Borda, I., and Posada de la Paz, M. (1992) Clinical findings. In Toxic Oil Syndrome: current knowledge and future perspectives (Nadal, J., and Tarkowski, S., Eds.) pp 26-36, WHO Regional Publications, European Series 42, World Health Organization Regional Office for Europe, Copenhagen, Denmark.
8. Gómez de la Cámara, A., Posada de la Paz, M., Abaitua-Borda, I., Barainca-Oyagüe, M. T., Abraira-Santos, V., Diez-Ruiz-Navarro, M. D., and Terracini, B. (1998) Health Status Measurements in Toxic Oil Syndrome. J. Clin. Epidemiol. 51 (10), 867-873.
9. Nadal, J., and Tarkowski, S. (1992) Toxic Oil Syndrome: current knowledge and future perspectives, WHO Regional Publications, European Series 42, World Health Organization Regional Office for Europe, Copenhagen, Denmark.
10. Posada de la Paz, M., Philen, R. M., Abaitua Borda, I., Bernert, J. T., Bada-Gancedo, J. C., DuClos, P. J., and Kilbourne, E. M. (1996) Toxic Oil Syndrome: traceback of the toxic oil and evidence for a point source epidemic. Food Chem. Toxicol. 34 (3), 251-257.
11. Ventura Diaz, M. (1982) Conventional analysis of the available samples of purportedly toxic oils. Grasas Aceites (Seville) 33, 73-77.
12. Bernert, J. T., Kilbourne, E. M., Akins, J. R., Posada de la Paz, M., Meredith, N. K., Abaitua-Borda, I., and Wages, S. (1987) Compositional analysis of oil samples implicated in the Spanish toxic oil syndrome. J. Food Sci. 52, 1562-1569.
13. Aldridge, W. N. (1992) Experimental studies. In Toxic Oil Syndrome: current knowledge and future perspectives (Nadal, J., and Tarkowski, S., Eds.) pp 63-93, WHO Regional Publications, European Series 42, World Health Organization Regional Office for Europe, Copenhagen, Denmark.
14. Kilbourne, E. M., Bernert, J. T., Posada de la Paz, M., Hill, R. H., Abaitua-Borda, I., Kilbourne, B. W., Zack, M. M., et al. (1988) Chemical correlates of pathogenicity of oils related to the toxic-oil syndrome epidemic in Spain. Am. J. Epidemiol. 127, 1210-1227.
15. Posada de la Paz, M., Philen, R. M., Abaitua-Borda, I., Diez-Ruiz Navarro, M., Abraira-Santos, V., Pozo, F., Pla-Mestre, R., Pollan-Santamaría, M., Sicilia-Socias, J. M., Azpeitia-Gamazo, P., Woodruff-Dyer, R., and Kilbourne, E. M. (1994) Factors associated with pathogenicity of oils related to the Toxic Oil Syndrome epidemic in Spain. Epidemiology 5, 404-409.
16. Vázquez-Roncero, A., Janer del Valle, C., Maestro-Duran, R., and Graciane-Constante, E. (1983) New aniline derivatives in cooking oils associated with the toxic oil syndrome. Lancet 2, 1024-1025.
17. Hill, R. H., Schurz, H. H., Posada de la Paz, M., Abaitua-Borda, I., Philen, R. M., Kilbourne, E. M., Head, S. L., Bailey, S. L., Driskell, W. J., Barr, J. R., and Needham, L. L. (1995) Possible etiologic agents for Toxic Oil Syndrome: fatty acid esters of 3-(N-phenylamino)-1,2-propanediol. Arch. Environ. Contam. Toxicol. 28, 259-264.
18. Schurz, H. H., Hill, R. H., Posada de la Paz, M., Philen, R. M., Abaitua-Borda, I., Bailey, S. L., and Needham, L. L. (1996) Products of aniline and triglycerides in oil samples associated with the Toxic Oil Syndrome. Chem. Res. Toxicol. 9, 1001-1006.
19. Posada de la Paz, M., Philen, R. M., Schurz, H. H., Hill, R. H., Gimenez-Ribota, O., Gómez de la Cámara, A., Kilbourne, E. M., and Abaitua-Borda, I. (1999) Epidemiologic evidence for a new class of compounds associated with Toxic Oil Syndrome. Epidemiology 10 (2), 130-134.
20. Nelson, S. D. (1985) Arylamines and Arylamides: oxidation mechanisms. In Bioactivation of Foreign Compounds (Anders, M. W., Ed.) pp 349-374, Academic Press, New York.
21. Hanna, P. E., and Banks, R. B. (1985) Arylhydroxylamines and arylhydroxamic acids: conjugation reactions. In Bioactivation of Foreign Compounds (Anders, M. W., Ed.) pp 375-402, Academic Press, New York.
22. Roots, I., Hildebrandt, A. G., Hirner, A., and Heinemeyer, G. (1982) High sensitivity of cytochrome P-450 reactions in human liver microsomes towards oleylanilide, the presumptive toxin in the Spanish oil epidemic 1981. Naunyn-Schmiedebergs Arch. Pharmacol. (Suppl.), R-30.
23. Vázquez-Roncero, A., Maestro-Duran, R., and Ruiz-Gutierrez, V. (1984) New aniline derivatives in oils related to the Toxic Syndrome. Toxicity in mice of 3-phenylamino-1,2-propanediol and its fatty acid mono- and diesters. Grasas Aceites (Seville) 35, 330-331.
24. Maestro-Duran, R., Ruiz-Gutierrez, V., and Vazquez-Roncero, V. (1985) Estudio toxicologico en ratones de nuevos derivados de la anilina presentes en aceites tóxicos. Rev. Toxicol. (Spain) 2 (3), 168-183.
25. Ruiz-Gutierrez, V., and Maestro-Duran, R. (1992) Lymphatic absorption of 3-phenyalmino-1,2-propanediol and its esters. Exp. Toxic. Pathol. 44, 29-33.
26. Carthew, P., Edwards, R. E., Dorman, B. M., and Verchoyle, R. D. (1995) A comparison of the acute pathology induced by 3-phenyalmino-1,2-propanediol (PAP) and its mono-oleoyl ester in rodents with the toxic oil syndrome in man. Hum. Exp. Toxicol. 14, 217-220.
27. Gallardo, S., Del Pozo, V., Cardaba, B., de Andrés, B., Martín-Orozco, E., Fernández, J. C., Tramon, P., Posada, M., Abaitua, I., Palomino, P., and Lahoz, C. (1994) Immunological basis of toxic oil syndrome (TOS). Toxicology 93, 289-299.
28. del Pozo, V., de Andrés, B., Gallardo, S., Cardaba, B., de Arruda-Chaves, E., Cortegano, I., Jurado, A., Palomino, P., Oliva, H., Aguilera, B., Posada, M., and Lahoz, C. (1997) Cytokine mRNA expression in lung tissue from Toxic Oil Syndrome patients: a Th2 immunological mechanism. Toxicology 118, 61-70.
29. Berking, C., Hobbs, M. V., Chatelain, R., Meurer, M., and Bell, S. A. (1998) Strain-dependent cytokine profile and susceptibility to oleic acid anilide in a murine model of the Toxic Oil Syndrome. Toxicol. Appl. Pharmacol. 148, 222-228.
30. Ferrer, M., Galceran, M., Sanchez-Baeza, F., Casas, J., and Messeguer, A. (1993) Synthesis of aniline derivatives with potential toxicological implications to the Spanish Toxic Oil Syndrome. Liebigs Ann. Chem., 507-511.
31. Guardiola, M., and Messeguer, A. (1998) Synthesis of tritium and carbon-14 labelled linoleic acid esters of 3-(phenylamino)-1,2-propanediol, compounds potentially involved in the etiology of the Toxic oil Syndrome. J. Labelled Compd. Radiopharm. 41, 75-80.
32. Adachi, J., Mio, T., Ueno, Y., Naito, T., Nishimura, A., Fujiwara, S., Sumino, K., and Tatsuno, Y. (1994) Identification of four metabolites of 3-(phenylamino)alanine, a constituent in L-tryptophan products implicated in eosinophilia-myalgia syndrome, in rats. Arch. Toxicol. 68, 500-505.
33. Chini, M., Crotti, P., Favero, L., Macchia, F., and Pineschi, M. (1994) Lanthanide(III) trifluoromethanesulfonates as extraordinarily effective new catalysts for the aminolysis of 1,2-epoxides. Tetrahedron Lett. 35, 433-436.
34. Benson, L. M., Tomlinson, A. J., Mayeno, A. N., Gleich, G. J., Wells, D., and Naylor, S. (1996) Membrane preconcentration-capillary electrophoresis-mass spectrometry (mPC-CE-MS) analysis of 3-phenylamino-1,2-propanediol (PAP) metabolites. J. High Resol. Chromatogr. 19, 291-294.
35. Okey, A. B., Riddick, D. S., and Harper, P. A. (1994) Molecular biology of the aromatic hydrocarbon (dioxin) receptor. Trends Pharmacol. Sci. 15, 226-232.
36. Vasiliou, V., Puga, A., and Nebert, D. W. (1993) Mouse class 3 aldehyde dehydrogenases: positive and negative regulation of gene expression. Adv. Exp. Med. Biol. 328, 131-139.
37. 1-450 mRNA with the use of cloned DNA probe. Effects of various P-450 inducers in C57BL/6N and DBA/2N mice. Mol. Pharmcol. 22, 779-786.
38. Landers, J. P., and Bunce, N. J. (1991) The Ah receptor and the mechanism of dioxin toxicity. Biochem. J. 276, 273-287.
39. Vasiliou, V., Kozak, C. A., Lindahl, R., and Nebert, D. W. (1996) Mouse microsomal class 3 aldehyde dehydrogenase: AHD3 cDNA sequence, inducibility by dioxin and clofibrate, and genetic mapping. DNA Cell Biol. 15, 235-245.
40. Philen, R., and Posada de la Paz, M. (1993) Toxic Oil Syndrome and Eosinophilia-Mialgia Syndrome: May 8-10, 1991 World Health Organization Meeting Report. Semin. Arthritis Rheum. 23 (2), 104-124.
41. Mayeno, A. N., Belongia, E. A., Lin, F., Lundy, S. K., and Gleich, G. J. (1992) 3-(Phenylamino)alanine, a novel aniline-derived amino acid associated with the eosinophilia-myalgia syndrome: a link to the toxic oil syndrome? Mayo Clin. Proc. 67, 1134-1139.
42. Mayeno, A. N., Benson, L. M., Naylor, S., Colberg-Beers, M., Puchalski, J. T., and Gleich, G. J. (1995) Biotransformation of 3-(phenylamino)-1,2-propanediol to 3-(phenylamino)alanine: a chemical link between Toxic Oil Syndrome and Eosinophilia-Myalgia Syndrome. Chem. Res. Toxicol. 8, 911-916.
43. Adachi, J., Gómez, M., Smith, C. C., and Sternberg, E. M. (1995) Accumulation of 3-(phenylamino)alanine, a constituent in L-tryptophan products implicated in eosinophilia-myalgia-syndrome, in blood and organs of the Lewis rats. Arch. Toxicol. 69, 266-270.
44. Griem, P., Wulferink, M., Sachs, B., Gónzalez, J. B., and Gleichmann, E. (1998) Alergic and autoimmune reactions due to xenobiotics: how do they arise? Immunol. Today 19 (3), 133-141.
45. Hess, D. A., and Rieder, M. J. (1997) The role of reactive drug metabolites in immune-mediated adverse drug reactions. Ann. Pharmacother. 31 (11), 1378-1387.
46. Kubicka-Muranyi, M., Goebels, R., Goebel, C., Uetrecht, J., and Gleichmann, E. (1993) T Lymphocytes ignore procainamide, but respond to its reactive metabolites in peritoneal cells: demonstration by the adoptive transfer popliteal lymph node assay. Toxicol. Appl. Pharmacol. 122, 88-94.